The adherence of microorganisms to platelets previously immobilized on the subendocardium in nonbacterial thrombotic endocarditis is considered an important pathogenic step in Staphylococcus aureus endocarditis. To identify and characterize bacterial factors involved in the adherence to platelets, a phage display library of S. aureus was generated by use of the phagemid pG8H6. The library was affinity panned against purified immobilized platelets. After a second panning against platelets, a significant increase in the number of eluted phagemid particles was observed; 27% of 88 randomly isolated clones expressed overlapping deduced amino acid sequences with high similarity to the C-terminal domain of the S. aureus coagulase. In addition, 22% of the clones expressed the N-terminal domain of the fibrinogenbinding protein Efb. The surface-associated fraction of the C-terminal domain of coagulase or the N-terminal domain of Efb may be involved in bacterial adherence to immobilized platelets, and fibrinogen may act as a bridging molecule in that interaction.
Staphylococcus aureus is an important cause of acute infective endocarditis. The pathogenesis of infective endocarditis is a complex process involving initial endocardial damage that results in exposure of the subendothelial matrix and deposition of fibrin and platelets [1, 2] . Subsequently, bloodborne pathogens adhere at this traumatized site [3] . Platelets are thought to play a major role in the induction and propagation of this disease; that is, platelets that are bound to damaged valve surfaces may serve as foci for the binding of bacteria circulating in the blood [4] . Subsequently, the attached bacteria may cause further platelet aggregation leading to an increase in the size of the infected vegetation on the valves [2, 5] .
The ability of surface-immobilized activated platelets to promote adherence of S. aureus has been demonstrated in vitro [6] . As in device-related infections, a role for extracellular matrix proteins, such as fibrinogen (Fg), fibronectin, and thrombospondin, has been suggested in the pathogenesis of endocarditis [7, 8] . S. aureus has different surface determinants, which potentially mediate adherence to damaged valves and promote endocarditis (e.g., Fg-and fibronectin-binding proteins) [9] [10] [11] . The regulatory locus sar of S. aureus, which is involved in the expression of these and other cell wall proteins, plays a role in the initial adherence of S. aureus to the fibrin-platelet matrix found on the damaged endothelium [12] . However, a direct binding of bacteria to platelet surface components is also postulated as a central mechanism in the pathogenesis of infective endocarditis [4] . The Fg-binding clumping factor (ClfA) that is important for the development of experimental endocarditis was recently shown to mediate direct binding of S. aureus to platelets [13, 14] . Another newly identified mechanism for the interaction of S. aureus with platelets involves the binding of protein A to the platelet membrane protein gC1qR/p33 [15] .
It is possible to identify the ligand-binding domain(s) of a prokaryotic receptor by cloning random genomic DNA fragments into a phagemid vector, followed by ligand affinity selection of the phagemid particles that surface express portions of the receptor [16] [17] [18] . To identify bacterial factors that are involved in the staphylococcal-platelet interaction, we constructed a phage display library of S. aureus 4074 and used gelfiltered immobilized platelets for affinity selection of plateletbinding phagemid particles.
Materials and Methods
Bacterial strains, phagemid vector, helper phage, plasmid, and media. S. aureus strains 4074, 4092, and 4075 were isolated from different sites of a patient with a native valve endocarditis at the Institute of Medical Microbiology, University of Mü nster. These strains, plus the laboratory strains S. aureus RN6390 [19] , Cowan1 (ATCC 12598), and SA113 [20] , were used to analyze adherence to platelets. S. aureus 4074 was used as a DNA donor strain in the construction of the phage display library. The construction of the library and the production of the enriched phage stocks were done in the host strain Escherichia coli TG1 (F ϩ and amber suppressing) [21] . E. coli MC1061 (F Ϫ ; provided by K. Hantke, University of Tü bingen, Tü bingen, Germany) was used to propagate the phagemid vector pG8H6. Recombinant phagemid DNA for sequencing was prepared from E. coli DH5a [22] . Phage R408 (Promega) was used as a helper phage. The phagemid pG8H6 (provided by K. Jacobsson, Swedish University of Agricultural Sciences, Uppsala, Sweden) was used as the vector in construction of the library [17] . Cloning of the 5 and 3 portion of coa and the 3 portion of efb from S. aureus 4074, respectively, was performed in E. coli DH5a by use of the vector pUC18 [23] .
S. aureus strains were grown on blood agar plates, in brain-heart infusion broth (Difco) or B-medium [24] . E. coli strains were cultivated in Luria-Bertani (LB) medium (Difco) or on LA plates (LB medium with 1.5% agar; Difco), which contained 50 mg/mL ampicillin when appropriate. E. coli TG1 was grown on M9-minimal agar to maintain the F plasmid [25] .
DNA manipulations, transformation of E. coli, preparation of phage stocks, and DNA sequencing. All DNA manipulations, transformation of E. coli, and preparation of phage stocks were done by standard procedures [25] . Chromosomal DNA from S. aureus was prepared according to the procedure of Marmur [26] . Plasmid DNA was isolated by use of the Qiagen plasmid kit by following the manufacturer's instructions (Qiagen). The polymerase chain reaction (PCR) was carried out with Taq DNA polymerase (Boehringer Mannheim) in accordance with the protocol of the supplier. All primers were synthesized by MWG-Biotech. DNA sequences of both strands were determined by the dideoxy chain-termination method [27] and the cycle sequencing protocol involving the GeneAmp PCR system 2400 (Perkin Elmer) on an ABI Prism 310 genetic analyzer (Perkin Elmer) or by MWG-Biotech by use of a LI-COR DNA sequencer.
The primers used for sequencing of hybrid phagemids had the following sequences: Pe, 5 -TTG CCT ACG GCA GCC GCT GAA-3 and My, 5 -TGC GGC CCC ATT CAG ATC CTC-3 [16] . The M13 forward and M13 reverse primers were used for sequencing the plasmids pCH4/4, pCH2/5, and pCH1/2 containing the 5 and 3 portions of the coa gene and the 3 portion of the efb gene, respectively, in the vector pUC18 (see below). The DNA sequences and the deduced protein sequences were analyzed with the computer program PC/GENE (IntelliGenetics). We compared the deduced protein sequences with those of known proteins by use of the BLASTP [28] and FASTA [29] software programs.
Purification of platelets, GPIIb/IIIa, and glycocalicin. Platelets were purified as described elsewhere [30] . In brief, blood samples (10 mL) were collected in tubes containing ACD (5 mM citric acid, 10 mM sodium citrate, and 15 mM dextrose). Platelet-rich plasma was prepared by centrifugation of whole blood at 180 g for 10 min. Platelets were separated from plasma proteins by passage of the platelet-rich plasma through a Sepharose 2B column (Pharmacia) with a 40-mL total bed volume. The column was equilibrated with calcium-free Hepes-Tyrode's (HT) buffer, pH 7.3 (136 nM NaCl, 2.7 nM KCl, 3.3 mM NaH 2 PO 4 , 10.5 mM HEPES salt, 4.45 mM HEPES acid, 2 mM MgCl 2 , 0.1% dextrose, and 0.1% human serum albumin [HSA]). Functional intact GPIIb/IIIa was purified as described elsewhere [31] , and glycocalicin, the soluble part of glycoprotein Ib, was purified as described in [32] and [33] .
In vitro assay for staphylococcal adherence to immobilized platelets. We analyzed the adherence of different S. aureus strains to platelet-coated surfaces with an in vitro assay, as described elsewhere [6] . In brief, polymethylmethacrylate (PMMA) coverslips were incubated with 40 mL of gel-purified platelets (15 min, 37ЊC) and then washed (15 min, 37ЊC) with HT buffer. Subsequently, the coverslips in a test tube were incubated (60 min, 37ЊC) with 1 mL of HT buffer containing CaCl 2 (1 mM) and staphylococci (10 6 cfu/ mL radiolabeled with 50 mCi of [ 3 H]thymidine; Amersham-Buchler). Thereafter, fluids were decanted, coverslips were washed twice, and adherent radioactivity was determined by liquid scintillation analyzer TRI-CARB 2100 TR (Canberra Packard). As a negative control, radiolabeled S. aureus cells were incubated with uncoated coverslips in the presence of 0.5% HSA to block nonspecific adhesion to the polymer surface. Percent adherence was calculated as (adherent radioactivity/inoculated radioactivity) ϫ 100. The fold increase of adherence promotion by platelets was calculated as percent adherence to platelets/percent adherence to human albumin.
Construction of the phagemid library. The phagemid library was constructed essentially as described by Jacobsson and Frykberg [17] . In brief, chromosomal DNA of S. aureus 4074 was randomly fragmented by sonication into fragments of ∼200-800 bp. The fragments were made blunt ended with T 4 polymerase and ligated into the SmaI-linearized and dephosphorylated vector pG8H6. The ligation mixture was phenol and chloroform extracted, ethanol precipitated, and dissolved in double-distilled H 2 O. After electrotransformation into E. coli TG1 and cultivation of the transformants in 100 mL of LB supplemented with 50 mg/mL ampicillin (37ЊC, 18 h), an aliquot of the transformants (4 mL) was infected with helper phage R408 at an MOI of 50 and incubated (37ЊC, 15 min). The infected cells were then mixed with 100 mL of 0.5% soft agar and poured onto 20 LA plates containing ampicillin. Following overnight incubation, the phage particles were eluted from the soft agar in 100 mL of LB (room temperature, 3 h, 150 rpm). The agar and bacteria were removed by centrifugation at 40,000 g for 15 min. The phage-containing supernatant was filter sterilized and the resulting library was frozen in aliquots. The titer of the library was determined by infection of E. coli TG1, followed by plating on LA plates containing ampicillin.
Panning procedure. Panning was done as described by Jacobsson and Frykberg [17] , with the following modifications due to the ligand being used for affinity selection. For the panning against glycocalicin and GPIIb/IIIa, 3 wells of a 96-well microtiter plate (tissue culture plate [Greiner]) were coated overnight at 4ЊC with 200 mL of glycocalicin (100 mg/mL in TBS buffer, pH 7.4) or GPIIb/IIIa (50 mg/mL in 20 mM Tris/HCl, pH 7.5, 0.15 M NaCl, 0.1% Triton X-100 [Boehringer Mannheim, membrane research grade], 1 mM CaCl 2 , and 50% glycerol), respectively. For panning against immobilized platelets, 3 wells of a microtiter plate (tissue culture plate [Greiner]) were coated with 200 mL of gel-filtered platelets (30 min, 37ЊC). The wells were then blocked with HT buffer containing 1% HSA (room temperature, 1 h). After the wells were washed 5 times with HT buffer, 200 mL of the phagemid library in HT buffer containing 1 mM CaCl 2 were added to the wells, and the microtiter plates were incubated (room temperature, 4 h). Afterward, the wells were washed 20 times with PBS con- taining 0.1% Tween 20 (Merck) and twice with 50 mM Na-citrate/ 140 mM NaCl, pH 5.5. Finally, bound phages were eluted stepwise in the same buffer with decreasing pH (3.7 and 2.1).
The eluates were neutralized with 60 mL of 2 M Tris/HCl, pH 8.7. Aliquots of the eluates were used to infect E. coli TG1 cells, which were then grown on LA plates containing 2% glucose and 50 mg/mL ampicillin. We suspended 10 2 -10 3 colonies from each elution in LB, which were infected with helper phage R408 for production of enriched phage stocks and then used for an identical second panning procedure. After the second round of panning, aliquots of the eluates were used to infect E. coli cells, resulting in the colonies that were analyzed.
Cloning of the 5 and 3 portions of the coa and the 3 portion of the efb genes. The 5 portion of coa was amplified from chromosomal DNA from strain 4074 by PCR using primers CH42, 5 -CAGGGATCCGTTTATTCTAGTTAATATATAGTTAAT-GTC-3 (upper primer, including nt 1-30 of the sequence for the coa gene [EMBL accession no. AJ306908]; BamHI restriction site is underlined), and CHCoa1, 5 -CAGGGTACCGACCTTCTAA-AATAGGGTTCG-3 (lower primer, including nt 1330-1350 of the sequence for the coa gene; KpnI restriction site is underlined), yielding an ∼1370-bp fragment. The 3 portion of coa was amplified by PCR by use of the primers CHCoa2, 5 -CAGGGTACCGAGATG-CTGGTACAGGTATCCG-3 (upper primer, including nt 1528-1549 of the sequence for the coa gene; KpnI restriction site is underlined), and CH41, 5 -CAGGGTACCTTATTTTGTTACTCT-AGGCCCATATGTCGC-3 (lower primer, including nt 2136-2165 of the sequence for the coa gene; KpnI restriction site is underlined), yielding an ∼650-bp fragment.
For PCR amplification of the 3 portion of efb from chromosomal DNA of strain 4074, we used primers CH52, 5 -CAGGGA-TCCGATGGTACATTCGAATATGGTGCGCGTCC-3 (upper primer, including nt 361-388 of the sequence for the efb gene [EMBL accession no. AJ306909 ]; BamHI restriction site is underlined), and CH51, 5 -CAGGGTACCTTATCTCACTAATCC-TTGTTTTAATACATTATC-3 (lower primer, including nt 589-611 of the sequence for the efb gene; KpnI restriction site is underlined), which yielded an ∼270-bp fragment.
The respective PCR fragments were ligated with the vector pUC18, and E. coli DH5a was transformed with the ligation mixture. Ampicillin was used to select transformants. Representative plasmids were designated pCH4/4 (5 portion of coa), pCH2/5 (3 portion of coa), and pCH1/2 (3 -portion of efb).
Results

Staphylococcal Adherence to Immobilized Platelets
To select a DNA donor strain in the construction of the phagemid library, we analyzed different S. aureus strains, including laboratory strains and clinical isolates associated with endocarditis, for their ability to bind to platelets in an in vitro adherence assay. Figure 1 shows the result of the adherence assay. Adhesion of different S. aureus strains to uncoated coverslips was low, ranging from 0.1% ‫%30.0ע(‬ SD, ) for S. n p 4 aureus 4074 to 0.5% ‫%1.0ע(‬ SD, ) for S. aureus RN6390. n p 4 Adhesion of S. aureus strains to immobilized platelets ranged from 1.5% ‫%62.0ע(‬ SD, ) for strain SA113 to 4% ‫%7.1ע(‬ n p 4 SD, ) for strain 4075. Thus, the presence of platelets adn p 4 herent to PMMA promoted adhesion 6-fold (S. aureus RN6390; SA113), 13-fold (Cowan1), 16-fold (4092), 20-fold (4075), or 28-fold (4074), respectively, compared with uncoated PMMA. The clinical isolates 4074, 4075, and 4092 showed a stronger promotion of adherence by platelets than the laboratory strains. Because the promotion of adherence by platelets was most pronounced with strain 4074, this strain was chosen as the DNA donor strain for construction of the phage display library.
Phage Display Library
We used the phagemid vector pG8H6 to construct a phage display library by random insertion of fragmented chromosomal DNA of S. aureus 4074 into gene VIII of the phagemid vector [17] . The phage display library consisted of 10 6 clones and had, after infection with helper phage, a titer of 10 3 ϫ 10 cfu/mL. About 94% of all clones had an insert with an average size of 280 bp. Thus, according to the criteria of Clarke and Carbon [34] , the library was representative of the S. aureus genome and should therefore express portions of all proteins encoded by the genome in fusion to the major coat protein VIII (pVIII).
Panning of the Library against Different Ligands
To identify platelet-binding domain(s) of bacterial receptors, the library was affinity panned against gel-filtered immobilized platelets. As a negative control, panning against HSA was performed because S. aureus has not been demonstrated to have a receptor for HSA. Table 1 shows the results from panning of the library against immobilized platelets and HSA. About 5 times more phages were eluted at pH 3.7 and pH 2.1 when panning was carried out against immobilized platelets in contrast with HSA. The eluted phagemid particles were used for production of secondary phage stocks in E. coli TG1 and were used in the repannings. In order to confirm that any enrichment in the repanning against platelets was due to affinity selection for the ligand and not to nonspecific interactions, the secondary phage stocks were also panned against HSA. Platelet repanning of the platelet affinity-selected phages resulted in ∼40-fold enrichment. This enrichment was specific because 100 times fewer phages were eluted when repanning was performed against HSA. Panning and repanning against HSA did not increase the number of eluted phages, suggesting that no enrichment is observed when bacteria do not express a specific receptor. Because the platelet receptors GPIIb/IIIa and GPIb are present in high copy number in the platelet membrane (80,000 or 50,000 copies/platelet, respectively), panning was also carried out against the purified integrin-receptor GPIIb/IIIa or the purified soluble part, glycocalicin, of the GPIb receptor, respectively, to determine if there is specific binding of an S. aureus protein directly to GPIIb/IIIa or GPIb. The numbers of eluted phages after repanning against GPIIb/IIIa as well as glycocalicin did not differ markedly from the number of eluted phages after the first panning (∼10 5 phagemid particles/mL). In the case of fibronectin, Jacobsson and Frykberg [17] isolated specific binding phagemid clones, although only an ∼5-fold increase in the eluted phagemids after the repanning was observed. Therefore, we analyzed the DNA sequences of the inserts of several eluted phagemid clones; however, none of the determined DNA sequences revealed that expression of a fusion protein was involved in specific binding to either GPIIb/IIIa or glycocalicin.
Analysis of Affinity-Selected Clones by Panning against Platelets
Determination of inserted fragment size. Plasmid DNA of colonies obtained after repanning against platelets was prepared and restricted with XhoI and PstI. Analysis of the fragments by electrophoresis in 2% agarose gels revealed that among 88 clones chosen at random, several fragments were isolated repeatedly: 23% (20 clones) had an insert of 1.1 kb, 11% (10 clones) had a 800-bp insert, 6% had a 480-bp insert, 5% had a 460-bp insert, and 4.5% had a 380-bp insert.
Nucleotide sequence analysis of inserted fragments and respective genes. We determined the nucleotide sequence of repeatedly isolated clones. Sequence analysis of the 800-bp (represented by clone P43), 480-bp (clone P33), 460-bp (clone P27), and 380-bp (clone P24) fragments revealed that they share identical nucleotide sequences that encode the same protein domain in fusion with pVIII. Comparison of the deduced amino acid sequences with sequences of known proteins in the SwissProt database showed a high similarity with the C-terminal portion of coagulases or the Fg-binding protein FbpA ( figure 2A) . Alignment of clone P43 with the C-terminal portion of coagulases of strains BB and 8325-4 revealed 93% and 85% identical amino acids, respectively, and 88% identical amino acids with the C-terminal portion of FbpA. In contrast with the coagulases, FbpA contains a unique stretch of 11 aa (SVTLPSITGES) that shares homology with a cell wall anchor motif (LPXTG) found in many grampositive surface proteins [35, 36] .
To determine whether the corresponding protein in strain 4074 represented by the isolated phagemids contains the cell wall anchor-like homologue present in FbpA, we determined the whole nucleotide sequence of the respective gene present in strain 4074. Sequence analysis found no LPXTG-like motif in coagulase of strain 4074. A common structural feature of coagulase and FbpA are the homologous but not identical Cterminal repeats, which contain the Fg-binding domain. They consist of 27 aa each repeated 5 times (coagulases of strain 8325-4 [68.9 kDa]; FbpA [69.9 kDa]), 6 times (coagulases of figure 2A ). In contrast, the C-terminal repeats in the coagulase of strain 4074 are repeated 7 times, corresponding to a predicted size of 77.8 kDa. The N-terminal portion of coagulases of different strains and FbpA share only 56%-73% identical amino acids, resembling the different serogroups of the coagulases. However, the N-terminal portion of the coagulase of strain 4074 is 95% identical to the N-terminal portion of strain 8325-4. Sequence analysis of the 1.1-kb fragments (represented by clone P22) and comparison of the deduced aa sequence (102 aa) that is in fusion to pVIII with known proteins in the SwissProt database revealed 100% identity with the N-terminal portion of the 19-kDa Fg-binding protein Efb, previously referred to as Fib [39] (figure 2B). Efb contains 2 repeats of 22 aa in the N-terminal part of the protein that show moderate similarity to the C-terminal repeats found in coagulases [39] . The N-terminal region of Efb contains an Fg-binding domain. Cloning and sequence analysis of the 5 portion of the efb gene of strain 4074 revealed 100% identical aa with Efb from strain FDA486 and 98% identical aa with Efb from strain Newman and thus confirms the highly conserved nature of the efb gene [40] . In clone P22, expression of the fusion protein seems to be controlled by the endogenous efb promoter.
In all of their affinity-selected clones with correct inserts, Jacobsson and Frykberg [17] found frameshifts in the junction between the PelB leader and the inserts, shifted to either ϩ1 or Ϫ1. All clones but 1 had the correct reading frame in the junction between the insert and the c-myg tag. Similarly, we found frameshifts in the clones P43, P27, and P24 between the PelB leader and the inserts; only clone P33 had the correct reading frame in this junction (data not shown). All of our clones, including clone P22, had the correct reading frame in the junction between the insert and the c-myg tag. The occurrence of those frameshifts was not expected, because an openreading frame through the signal sequence, the inserted DNA, and gene VIII is necessary for expression of the recombinant protein. But, because it was possible to isolate correct clones by affinity selection, the foreign polypeptide must have been exposed at the phage surface. Thus, ribosomal slippage is required to express the fusion protein.
Ribosomal slippage is a phenomenon that can occur at socalled "slippery" sequences, which are a stretch of у4 single nucleotides [41] . Accordingly, at the SmaI site in the junction between the PelB leader and the insert, a stretch of 4 cytosines in a row is created [17] . The vector pG8H6 involves the major coat protein pVIII expressing fusion proteins at the phage surface. The phage capsid consists of ∼2700 copies of pVIII. As used in the phage display system and with the aid of the helper phage, hybrid phages contain a mixture of the wild-type pVIII and varying numbers of the fusion protein, depending on the insert. It appears likely that there is a strong selection against clones with the correct reading frame, because high expression of the fusion protein in E. coli may be toxic and the requirement for ribosomal slippage leads to a reduction of the expression of the fusion proteins. Hence, ribosomal slippage in different viral systems keeps the expression of distinct genes at a low level [42] . This hypothesis is further supported by our observation that the E. coli clone containing plasmid pP33, which is the only one representing the correct open-reading frame in the junction between the PelB leader and the insert, showed reduced growth and formed translucent colonies. In addition, plasmid pP33 was not stable in E. coli-producing different deletion derivatives, which may be regarded as another mechanism to keep the expression of the fusion protein low.
Confirmation of the Specificity of Binding of Affinity-Selected Phagemid Clones
To verify that, despite the wrong reading frames in the hybrid phagemid clones, affinity-selection of the phagemids was due to expression of fusion proteins, phage stocks of the clones P43 and P22 were prepared and diluted serially. The dilutions were mixed with a constant amount of a phage stock prepared from the vector pG8H6. These mixtures were panned against platelets. Eluted phages were used to infect E. coli TG1 cells, and isolated phagemids were analyzed by agarose gel electrophoresis. Table 2 shows that the relative numbers of eluted P43 and P22 phagemid clones were dramatically increased by affinity selection. This strongly suggests a specific binding of clones P43 and P22 to platelets due to expression of fusion proteins.
Discussion
We believe this work is the first to investigate the complex interaction between surface-adhering platelets and S. aureus by use of a screening method for protein-ligand interaction on the basis of the comprehensive representation and expression of the S. aureus genome in vector pG8H6. Detailed analysis of eluted phagemids revealed that 2 Fg-binding S. aureus proteins, coagulase and Efb, were highly and specifically enriched upon panning against whole platelets but not against the purified platelet receptors GPIIb/IIIa or GPIb.
In control panning experiments, we used endothelial cells to enrich for endothelial cell-binding phagemids. None of the phagemids that were recovered after the second round of panning against endothelial cells contained a portion of the genes encoding either the coagulase or Efb (data not shown). This suggested that the binding of the coagulase-and Efb-expressing phagemids was specific to platelets and not due to nonspecific binding to eukaryotic membranes. Coagulase and Efb are mainly secreted proteins. However, a small fraction of both proteins seems to remain surface associated [37, 43] . Therefore, it may be possible that the surface-associated fractions of coagulase and Efb are involved in S. aureus adherence to surfaceimmobilized, activated platelets. According to our findings, coagulase and Efb do not seem to bind to the platelet receptors glycoprotein GPIIb/IIIa and GPIb.
Because we isolated the Fg-binding portion of coagulase and Efb via panning against immobilized platelets, we assume that binding occurs via platelet-bound Fg as a bridging molecule. This hypothesis is supported by the findings of Jacobsson and Frykberg [17] , who used immobilized Fg to enrich for Fg-binding clones. Upon panning against Fg, these investigators isolated phagemid clones that contained inserts encoding either a portion of the C-terminal region of the coagulase (12 of 13 correct clones) or a portion of Efb (1 of 13 correct clones), and thus we affinity selected equivalent phagemid clones by panning against platelets.
The importance of Fg as a bridging molecule was shown in the staphylococcal adherence to cultured human endothelial cells [44] and platelets [45] . Fg is secreted from the a-granula during activation of platelets and is bound by the platelet GPIIb/IIIa receptor. However, S. aureus induces platelet aggregation via a mechanism that is Fg dependent but does not involve the Fg-binding domains of the glycoprotein GPIIb/IIIa [46] . Further analysis is necessary to clarify the mechanism by which Fg acts as a bridging molecule.
The degree of platelet binding differed among the clinical and laboratory S. aureus strains analyzed. The coagulase of strain SA113, which is a derivative of strain 8325-4 and which demonstrated the lowest platelet binding, contains only 5 repetitive sequences. In contrast, the coagulase of the highly adherent strain 4074 contains 7 repetitive sequences. These repeats were the domains that were affinity selected by panning against platelets and are known to exhibit Fg-binding activities. Therefore, it may be hypothesized that the number of repetitive sequences in their coagulases reflects the difference in the platelet binding among strains.
Coagulases have been assumed to be important virulence factors because of their procoagulant and Fg-binding activity [43] . The N-terminal half of coagulases contains a prothrombinbinding region. Coagulase binds to prothrombin in a 1:1 molar ratio to form the staphylothrombin complex, which converts Fg to fibrin visible as the clotting reaction in plasma [47] . On damaged heart valves, this coagulation reaction could lead to the formation of larger vegetations composed of fibrin and platelets and facilitate the adherence of more bacteria at this site. Our results suggest that binding of coagulase to platelets might enhance that process. However, in a rat model of endocarditis, a coagulase-negative mutant did not show decreased virulence in comparison with the wild-type strain [13] . In these experiments, the rats were sacrificed 12 h after challenge with the S. aureus wild-type or its coagulase-negative mutant. Therefore, it was concluded that the coagulase is not involved in the initiation of endocarditis but might be involved in later stages of infection. Indeed, an involvement of coagulase in virulence was suggested in a more recent study that used a murine model of hematogeneous pulmonary infection induced by S. aureus enmeshed in agar beads that were injected intravenously [48] . In that model, 7 days after inoculation, significantly more S. aureus wild-type cells compared with coagulase-negative mutant cells were recovered from infected lungs, suggesting that coagulase is not important in establishing an infection but is important in later stages by promoting bacterial proliferation in the tissue [48] .
Although Efb apparently does not participate in S. aureus adherence to immobilized Fg, it seems to be a virulence factor. In a rat wound infection model, the Efb-negative mutant showed significantly less severe signs of infection than the wildtype strain, suggesting that Efb plays a role in wound infection because it seems to delay the healing process [49] . Moreover, immunization against Efb protected against infection in a mouse mastitis model [50] . The actual biologic function of Efb in wound infection and the healing process is unknown. Possibly, the interference with the healing process is due to Efb binding to platelets.
Interaction of S. aureus with platelets is a multifactorial process, which makes it difficult to analyze selected factors [6, 14, 15, 46] . Here we demonstrated that the complexity of the interaction can be successfully dissected by phage display of the staphylococcal genome. Cloning and expression of the coa and efb genes in a non-S. aureus background such as S. carnosus [51, 52] and subsequent analysis of platelet-binding activity may more precisely define the role that coagulase and Efb play in the S. aureus platelet interaction. On the other hand, the use of S. aureus genomic phage display with platelets at modified experimental conditions (e.g., in suspension systems) or with platelet mutants will enhance our understanding of the S. aureus platelet interaction at different physiologic stages. Overall, these approaches will help to provide the basis for strategies aimed to interfere with the S. aureus platelet interaction in the pathogenesis of endovascular infection.
